IDEXX Laboratories
Preço: 560.88Empresa e modelo de negócios
IDEXX Laboratories is a global leader in veterinary diagnostics and software solutions. The company develops and manufactures a range of products for animal health, including diagnostic tests, instruments, and software for veterinary practices. Its major business segments include Companion Animal Group, Livestock, and Poultry, with the primary revenue source coming from diagnostic products and services for pets and livestock. IDEXX also offers water testing solutions and diagnostic products for dairy and poultry industries.
Perfil de investimento
The investment profile of IDEXX Laboratories is more aligned with growth investors, given its focus on innovation and expansion in the veterinary diagnostics market. The company has shown consistent revenue growth, although it faces higher risk factors. Investors seeking a balanced approach may find it suitable, but the absence of dividends may deter those focused on income.
Métricas fundamentais (experimental)
- EPS (TTM) — lucro por ação dos últimos 12 meses, $
- 13.67 OK
- Receita QoQ — crescimento da receita trimestre contra trimestre
- 4.6% ↑
- Surpresa de EPS
- 1.8% em linha
- Volatilidade 20d
- 1.7% estável
Acompanhar no portfólio
Gráfico de preço
| Data | Antes | Depois | Motivo |
|---|---|---|---|
| 2026-06-13 02:40 | Vender | Manter | Mixed performance; cautious due to negative momentum. |
| 2026-06-03 02:43 | Manter | Vender | Weak momentum and high risk overshadow potential upside. |
| 2026-05-24 02:41 | Vender | Manter | Weak momentum and high risk; cautious outlook advised. |
| Data | Analista | Action | Alvo | Preço na época |
|---|---|---|---|---|
| 2026-04-28 12:16 | UBS | Preço-alvo reduzido | 730 → 640 | 569.167 |
| 2026-02-09 11:54 | Piper Sandler | Preço-alvo reduzido | 775 → 750 | 644.61 |
| 2026-02-05 10:41 | Barclays | Preço-alvo reduzido | 850 → 800 | 642.94 |
Nada ainda